Cargando…
Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP
OBJECTIVES: A radiomics-based explainable eXtreme Gradient Boosting (XGBoost) model was developed to predict central cervical lymph node metastasis (CCLNM) in patients with papillary thyroid carcinoma (PTC), including positive and negative effects. METHODS: A total of 587 PTC patients admitted at Bi...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458917/ https://www.ncbi.nlm.nih.gov/pubmed/36091102 http://dx.doi.org/10.3389/fonc.2022.897596 |
_version_ | 1784786384335142912 |
---|---|
author | Shi, Yan Zou, Ying Liu, Jihua Wang, Yuanyuan Chen, Yingbin Sun, Fang Yang, Zhi Cui, Guanghe Zhu, Xijun Cui, Xu Liu, Feifei |
author_facet | Shi, Yan Zou, Ying Liu, Jihua Wang, Yuanyuan Chen, Yingbin Sun, Fang Yang, Zhi Cui, Guanghe Zhu, Xijun Cui, Xu Liu, Feifei |
author_sort | Shi, Yan |
collection | PubMed |
description | OBJECTIVES: A radiomics-based explainable eXtreme Gradient Boosting (XGBoost) model was developed to predict central cervical lymph node metastasis (CCLNM) in patients with papillary thyroid carcinoma (PTC), including positive and negative effects. METHODS: A total of 587 PTC patients admitted at Binzhou Medical University Hospital from 2017 to 2021 were analyzed retrospectively. The patients were randomized into the training and test cohorts with an 8:2 ratio. Radiomics features were extracted from ultrasound images of the primary PTC lesions. The minimum redundancy maximum relevance algorithm and the least absolute shrinkage and selection operator regression were used to select CCLNM positively-related features and radiomics scores were constructed. Clinical features, ultrasound features, and radiomics score were screened out by the Boruta algorithm, and the XGBoost model was constructed from these characteristics. SHapley Additive exPlanations (SHAP) was used for individualized and visualized interpretation. SHAP addressed the cognitive opacity of machine learning models. RESULTS: Eleven radiomics features were used to calculate the radiomics score. Five critical elements were used to build the XGBoost model: capsular invasion, radiomics score, diameter, age, and calcification. The area under the curve was 91.53% and 90.88% in the training and test cohorts, respectively. SHAP plots showed the influence of each parameter on the XGBoost model, including positive (i.e., capsular invasion, radiomics score, diameter, and calcification) and negative (i.e., age) impacts. The XGBoost model outperformed the radiologist, increasing the AUC by 44%. CONCLUSIONS: The radiomics-based XGBoost model predicted CCLNM in PTC patients. Visual interpretation using SHAP made the model an effective tool for preoperative guidance of clinical procedures, including positive and negative impacts. |
format | Online Article Text |
id | pubmed-9458917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94589172022-09-10 Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP Shi, Yan Zou, Ying Liu, Jihua Wang, Yuanyuan Chen, Yingbin Sun, Fang Yang, Zhi Cui, Guanghe Zhu, Xijun Cui, Xu Liu, Feifei Front Oncol Oncology OBJECTIVES: A radiomics-based explainable eXtreme Gradient Boosting (XGBoost) model was developed to predict central cervical lymph node metastasis (CCLNM) in patients with papillary thyroid carcinoma (PTC), including positive and negative effects. METHODS: A total of 587 PTC patients admitted at Binzhou Medical University Hospital from 2017 to 2021 were analyzed retrospectively. The patients were randomized into the training and test cohorts with an 8:2 ratio. Radiomics features were extracted from ultrasound images of the primary PTC lesions. The minimum redundancy maximum relevance algorithm and the least absolute shrinkage and selection operator regression were used to select CCLNM positively-related features and radiomics scores were constructed. Clinical features, ultrasound features, and radiomics score were screened out by the Boruta algorithm, and the XGBoost model was constructed from these characteristics. SHapley Additive exPlanations (SHAP) was used for individualized and visualized interpretation. SHAP addressed the cognitive opacity of machine learning models. RESULTS: Eleven radiomics features were used to calculate the radiomics score. Five critical elements were used to build the XGBoost model: capsular invasion, radiomics score, diameter, age, and calcification. The area under the curve was 91.53% and 90.88% in the training and test cohorts, respectively. SHAP plots showed the influence of each parameter on the XGBoost model, including positive (i.e., capsular invasion, radiomics score, diameter, and calcification) and negative (i.e., age) impacts. The XGBoost model outperformed the radiologist, increasing the AUC by 44%. CONCLUSIONS: The radiomics-based XGBoost model predicted CCLNM in PTC patients. Visual interpretation using SHAP made the model an effective tool for preoperative guidance of clinical procedures, including positive and negative impacts. Frontiers Media S.A. 2022-08-26 /pmc/articles/PMC9458917/ /pubmed/36091102 http://dx.doi.org/10.3389/fonc.2022.897596 Text en Copyright © 2022 Shi, Zou, Liu, Wang, Chen, Sun, Yang, Cui, Zhu, Cui and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Shi, Yan Zou, Ying Liu, Jihua Wang, Yuanyuan Chen, Yingbin Sun, Fang Yang, Zhi Cui, Guanghe Zhu, Xijun Cui, Xu Liu, Feifei Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP |
title | Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP |
title_full | Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP |
title_fullStr | Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP |
title_full_unstemmed | Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP |
title_short | Ultrasound-based radiomics XGBoost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual application of SHAP |
title_sort | ultrasound-based radiomics xgboost model to assess the risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: individual application of shap |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458917/ https://www.ncbi.nlm.nih.gov/pubmed/36091102 http://dx.doi.org/10.3389/fonc.2022.897596 |
work_keys_str_mv | AT shiyan ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap AT zouying ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap AT liujihua ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap AT wangyuanyuan ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap AT chenyingbin ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap AT sunfang ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap AT yangzhi ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap AT cuiguanghe ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap AT zhuxijun ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap AT cuixu ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap AT liufeifei ultrasoundbasedradiomicsxgboostmodeltoassesstheriskofcentralcervicallymphnodemetastasisinpatientswithpapillarythyroidcarcinomaindividualapplicationofshap |